About Forkhead box protein D2
Forkhead box protein D2 (FOXD2) is a protein
from Homo sapiens identified by UniProt accession
O60548, 495 residues long.
MolForge cross-references it against 0 known binders and
212 disease associations.
Target properties
| Protein name | Forkhead box protein D2 |
| UniProt accession | O60548 |
| Gene | FOXD2 |
| Organism | Homo sapiens |
| Length | 495 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (212)
Diseases linked to this target (Open Targets).
- body height · score 0.45
- brain volume measurement · score 0.41
- neuroimaging measurement · score 0.40
- brain measurement · score 0.39
- hemoglobin measurement · score 0.39
- urinary albumin to creatinine ratio · score 0.39
- cortical surface area measurement · score 0.39
- cortical thickness · score 0.39
- hematocrit · score 0.38
- erythrocyte count · score 0.35
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O60548-F1 | alphafold | PREDICTED | 53.99 | — |
Amino-acid sequence (495 residues)
MTLGSCCCEI MSSESSPAAL SEADADIDVV GGGSGGGELP ARSGPRAPRD VLPHGHEPPA EEAEADLAED EEESGGCSDG EPRALASRGA AAAAGSPGPG AAAARGAAGP GPGPPSGGAA TRSPLVKPPY SYIALITMAI LQSPKKRLTL SEICEFISGR FPYYREKFPA WQNSIRHNLS LNDCFVKIPR EPGNPGKGNY WTLDPESADM FDNGSFLRRR KRFKRQPLPP PHPHPHPHPE LLLRGGAAAA GDPGAFLPGF AAYGAYGYGY GLALPAYGAP PPGPAPHPHP HPHAFAFAAA AAAAPCQLSV PPGRAAAPPP GPPTASVFAG AGSAPAPAPA SGSGPGPGPA GLPAFLGAEL GCAKAFYAAS LSPPAAGTAA GLPTALLRQG LKTDAGGGAG GGGAGAGQRP SFSIDHIMGH GGGGAAPPGA GEGSPGPPFA AAAGPGGQAQ VLAMLTAPAL APVAGHIRLS HPGDALLSSG SRFASKVAGL SGCHF
Explore Forkhead box protein D2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets